Tau neurofibrillary tangle pathology characterizes Alzheimer's disease and other neurodegenerative tauopathies. Brain gene expression profiles can reveal mechanisms; however, few studies have systematically examined both the transcriptome and proteome or differentiated Tau-versus agedependent changes.
Results

Paired Tau transcriptomes and proteomes in Drosophila
Longitudinal, parallel RNA-seq and mass-spectrometry proteomics were performed in controls (elav-GAL4) and in flies with pan-neuronal expression of human wildtype (elav>Tau WT ) or mutant Tau (elav>Tau R406W ). The transgenic genotypes and age timepoints (1-, 10-, and 20-days) selected for this analysis have been extensively characterized in prior published work [6, 24] , and we confirmed that Tau WT and Tau R406W are expressed at similar levels (Additional file 1: Figure S1 ). Overall, 17,104 transcripts and 2,723 proteins were detected. We first analyzed our results cross-sectionally, highlighting those transcripts or proteins significantly differentially expressed (FDR < 0.05) at each timepoint (Table   1 ; Additional File 2: Table S1 ). Overall, Tau WT altered expression of 1,514 transcripts and 213 proteins.
At each age examined, Tau R406W induced a ~4-to 7-fold greater number of differentially expressed genes than Tau WT , highlighting 5,494 transcripts and 697 proteins. There was substantial overlap between the Tau WT and Tau R406W gene expression profiles, with 70% of Tau WT -associated transcripts showing consistent changes in Tau R406W flies (65% of proteins) (Additional File 1: Figure S2 ). Overall, nearly equal numbers of up-or down-regulated, differentially expressed genes were detected in the Tau transcriptome; whereas in the proteome, Tau-induced gene up-regulation was more common by a factor of 2, which may reflect reduced assay sensitivity for proteins with low expression levels.
As in human tauopathy, the neurodegenerative phenotypes manifested by Tau transgenic flies are progressive with aging [24] . Consistent with this, we observed age-dependent differences in the number and identity of differentially expressed genes across the timepoints examined (Additional File 1: Figure   S2 ). For example, only a minority (~9%) of transcripts from Tau WT flies were consistently, differentially expressed at all 3 timepoints. The profound impact of aging on the Drosophila brain transcriptome and proteome is readily apparent in transcriptome-wide heatmaps (Fig. 1a,b ) and unsupervised clustering analysis further highlights age as a major driver of gene expression differences among samples (Additional File 1: Figure S3 ). Indeed, among control animals, we documented age-related, differential expression of 6,742 transcripts and 1,155 proteins ( Table 2 and Additional File 2: Tables S2, S3 ), and similar changes were seen in analyses of aged Tau animals (within genotype comparisons of data from different timepoints). Strikingly, approximately 70% of Tau-triggered transcripts overlap aging-associated gene expression changes. These data highlight an intimate connection between aging and Tau-mediated perturbations in gene expression.
Integrated longitudinal analysis of differentially expressed transcripts and proteins
In order to identify the most robust, Tau-induced expression changes independent of aging, we used linear regression and considered all longitudinal data in a joint model, including a covariate to adjust for age. In separate analyses of Tau WT and Tau R406W , we identify 1,653 and 4,992 significant differentially expressed transcripts, respectively ( Table 1 and Additional File 2: Table S4 ). The same approach was applied to the longitudinal proteomic data. To better understand the joint impact of Tau on the transcriptome and proteome, we next examined those genes detected by both the RNA-seq and mass-spectrometry assays (n=2,395 and 2,423 for Tau WT and Tau R406W , respectively). For this and subsequent analyses, we focus on the Tau R406W dataset given the more substantial number of differential expression changes (analyses of Tau WT are included as supplemental data and show consistent results). Remarkably, among 1, 309 Tau R406W -triggered, differentially expressed transcripts with corresponding proteome measurement, only 58% show concordant changes in the proteome (same direction of change, regardless of significance) ( Fig. 1c and Additional File 1: Figure S4 ). These data indicate that for a substantial proportion of transcriptional changes (42%), the behavior of corresponding proteins is discordant. Consistent with this, out of 503 significant, differentially expressed proteins induced by Tau R406W , 272 (48%) are unique to the proteome (e.g. either non-significantly changed or not detected in the transcriptome).
Tau-mediated perturbations of the transcriptome and proteome are readily appreciated in an integrated plot ( Fig. 1c ) including all significant, differentially expressed transcripts and/or proteins, and representative examples discussed below are highlighted in Fig. 2 (see also Additional File 1: Figure S5 ).
Concordant activation or suppression of gene activation, respectively, is represented in the upper right (I) and lower left quadrants (III) of the plot. Many Tau-responsive genes show highly consistent and concordant expression changes in transcripts and proteins. Transferrin 1 (Tsf1) encoding an iron-binding protein induced during the Drosophila innate immune response [33] is strongly activated by Tau R406W , showing similar ~2-fold increase in both the transcriptome and proteome, and these changes are largely consistent in 1-, 10-, and 20-day-old animals. Reciprocally, Synaptotagmin-1 (Syt1), encoding the essential calcium sensor for synaptic vesicle release and neurotransmission [34] , is decreased 10% at the transcript level and 40% at the protein level, and this result agrees with prior targeted studies of synaptic proteins in Tau R406W flies [35] . By contrast, Tau-triggered gene expression changes that are discordant between the transcriptome and proteome occupy the upper left (II) and lower right (IV) quadrants of the plot (Fig. 1c ). For example, Synaptobrevin (nSyb), which participates in synaptic vesicle fusion and release [36] , is increased in Tau flies, whereas nSyb transcripts are reciprocally decreased. Alternatively, in the case of Sar1, encoding a GTPase involved in endocytic trafficking [37] , we detect a Tau-associated increase in transcripts, whereas Sar1 protein is decreased. Such discordant changes may suggest the possibility of feedback regulation between the transcriptome and proteome. In other cases, we detect significant Tau-induced changes in the proteome without a corresponding change in transcript levels. One such example is CCT1, encoding a cytosolic chaperone implicated in cytoskeletal regulation and nerve injury response [38] .
As suggested above, aging has a profound impact on brain gene expression and frequently modifies the impact of Tau, sometimes with divergent consequences in the transcriptome and proteome.
For example, aging is associated with a substantial increase in Tsf1 transcript expression in both Tau and control animals (~3-and 6-fold, respectively), whereas protein expression appears stable over the same timecourse. The immune response gene, Attacin-A (AttA), encoding an antimicrobial peptide, provides another striking example. RNA-seq reveals a consistent aging-and Tau-associated increase in AttA transcripts. However, the substantial Tau-associated increase observed in the proteome of 1-day-old flies is attenuated during aging and no longer detected by 20-days (genotype x age interaction, p=3.78x10 -3 ).
The sharp increase of AttA in wildtype flies with aging was previously reported and linked to neuronal maintenance [39] . Notably, in our age-adjusted joint model, only 35% of Tau-triggered differentially expressed transcripts were fully independent of aging. By contrast, the majority (65%) were both Tauand aging-associated gene expression changes (Additional File 1: Figure S6 ). Given the pervasive impact of aging, we again carefully considered all aging-associated changes, focusing on relative changes across the transcriptome and proteome, as well as a potential interaction with Tau-mediated toxicity ( Table 2 and   Additional File 2: Table S2, S3 ). Interestingly, in Tau R406W flies we note an ~18% increase in agingassociated transcripts, with 7,970 genes affected (versus 6,742 in controls). However, within the proteome, the reverse pattern is seen with only 258 age-associated protein changes detected (versus 1,155 in controls), representing a 78% reduction, and potentially consistent with reports of Tau-induced translational dysregulation [40] [41] [42] . A similar trend for the proteome is observed in Tau WT animals; although, the magnitude of changes was more modest (Additional File 2: Table S3 ). In sum, these data reveal unexpected and dynamic interactions between Tau and aging and their divergent impact on the transcriptome and proteome.
Tau-induced gene expression networks implicate aging and innate immune pathways
In order to reveal the broader biological processes disrupted by Tau, we next performed overrepresentation analysis using gene ontology (GO) annotations (Additional File 2: Table S5 ). We again focused on the Tau R406W age-adjusted dataset, given the greater number of differential expression changes, and we initially examined the transcriptome. Complementary analyses of Tau WT are included in the supplemental data. Among all differentially expressed transcripts, we detected significant enrichment for genes implicated in the cytoskeleton (p<1x10 -20 ), endocytosis (p=8.9x10 -10 ), synaptic function (p=1.7x10 -6 ), innate immunity (p=8.9x10 -6 ), and translation (p=8.4x10 -4 ). One potential limitation of this approach is that it considers the entire transcriptome as a single regulatory unit and may therefore be underpowered to detect more restricted network modules. Therefore, in order to partition the transcriptomic data into coregulated gene sets, we implemented unsupervised hierarchical clustering and defined 6 discrete gene sets (n=33-1,863 genes; Additional File 2: Table S6 ), equally divided between Tau-associated up-and down-regulated groups (Fig. 3 ). As expected, each cluster was significantly enriched for genes corresponding to the biological pathways outlined above (Additional File 2: Table S7 ), consistent with identification of discrete transcriptional regulatory networks. Four gene clusters revealed strong age-dependent changes in both control and Tau flies, including both age-dependent decreases (clusters 1 & 3) or increases (clusters 2 & 4). As expected, these clusters (1-4) strongly overlap with ageassociated gene expression changes obtained from controls (mean=78%, range 66-85% overlap).
Interestingly however, we observe 2 distinct patterns for the relationship between Tau-and agingassociated transcriptome changes. First, in gene sets enriched for innate immune (cluster 2, increasing with age) or synaptic biology (cluster 1, decreasing with age), Tau amplifies the "aging expression signature". Conversely, in clusters 3 and 4-enriched for endocytic and chromatin biology, respectively-Tau opposes the age-associated changes. Thus, these 2 alternate patterns conform to accelerated versus delayed brain aging, based on the transcriptome responses. In contrast, neither of the remaining clusters reveal strong age-dependent changes in control flies, with Tau triggering decreased (cluster 5) or increased (cluster 6) gene expression. Interestingly, in cluster 5, enriched for mitochondrial and epithelial gene sets, the Tau-induced downregulation in the transcriptome appears to be attenuated by aging. As a complementary strategy to define Tau-associated gene regulatory networks, we also implemented weighted gene correlation network analysis (WGCNA), identifying 15 mutually exclusive transcriptional modules (Additional File 2: Table S6 ). Among these, we found 7 modules significantly associated with Tau genotype in Tau R406W flies (Additional File 1: Figure S7 ). Moreover, these modules substantially overlap with the gene sets defined using hierarchical clustering, resulting in similar functional enrichment profiles and recapitulating consistent interrelationships with aging (Additional File 2: Tables S6, S7 ).
In parallel analyses of the Tau R406W proteome dataset, we detected enrichment among differentially expressed proteins for translation (p=1.2x10 -7 ) and amino acid biosynthesis (p=7x10 -3 ), including a preponderance of ribosomal proteins (p<1x10 -20 ) (Additional File 2: Table S5 ). We next integrated the transcriptome derived clusters with complementary data from proteomics. Consistent with our analyses described above, we found variable concordance among the clusters, based on the direction of differential expression detected in the proteome (Additional File 1: Figure S8 ). For example, clusters enriched for immune and synaptic function were reciprocally up-or down-regulated in Tau animals, but both gene sets were predominantly (~60%) concordant in the proteome-differentially expressed proteins show consistent direction of change in Tau R406W flies. By contrast, cluster 5, implicated in mitochondrial and epithelial biology, showed only 39% concordance, suggesting opposing regulatory interactions between the transcriptome and proteome.
Cross-species annotation of Tau-specific changes from human brain gene expression profiles
Gene expression analysis from human postmortem brain tissue is confounded by mixed pathologies, making it difficult to identify those changes that are specifically triggered by Tau versus aging or other brain lesions. In contrast, our transcriptomic and proteomic analyses in flies benefit from matched experimental controls and longitudinal sampling, allowing definitive identification of Tau-triggered changes. We therefore leveraged our Drosophila results to annotate potential Tau-specific transcriptional changes from human brain gene expression profiles. We focused on 3 published analyses of differential gene expression, in relation to (i) AD clinical-pathologic diagnosis (n=478 cases / 300 controls; [10] ), (ii) PSP clinical-pathologic diagnosis (n=82 cases / 76 controls; [9] ), or (iii) neurofibrillary tangle pathologic burden (n=478 brains; [11] ). As expected, following homology mapping using the Drosophila Integrated Ortholog Prediction Tool [43] ; 57-66% of human genes had well-conserved fly homologs. The results of lookups are summarized in Table 3 , and detailed results are included in Additional File 2: Table S8 . In all 3 datasets, roughly half of conserved, differentially expressed changes are nominated as directly triggered by Tau pathology, based on cross-species annotation. Importantly, the observed human-fly overlaps appear more likely than that expected due to chance (hypergeometric test: AD, p=1.36x10 -63 ; PSP, p=8.63x10 -19 ; tangle burden, p=1.81x10 -48 ). Moreover, ~50-60% of overlapping differentially expressed genes were concordant across species (i.e. gene up-regulation in both human AD and Drosophila Tau transcriptomes) (Additional File 2: Table S8 ). In a complementary analysis, we also examined the differentially expressed gene sets from human postmortem brains for overlaps with Drosophila aginginduced gene expression changes ( Table 3 and Additional File 2: Table S8 ). An even greater proportion (~70%) of human genes altered in human tauopathy showed conserved changes during brain aging in flies. In fact, few human genes specifically overlapped with the Tau dataset, with 90% overlapping both the Tau-and aging differentially expressed gene sets. Lastly, we leveraged our fly proteomic data to annotate a recently reported mass-spectrometry dataset of differentially expressed proteins from 453 human brains, including 196 AD clinical-pathologic cases and 257 controls [19] . Despite the reduced depth of coverage for proteomics, this additional analysis highlights 63 proteins differentially expressed in human AD for which fly protein homologs are similarly dysregulated in response to Tau; 471 proteins overlapped with the complementary fly aging-dysregulated proteins.
Resolving amplifying versus protective expression changes using genetic modifiers
Tau-associated gene expression changes are excellent candidates for causal mechanisms in tauopathiesthose with the potential to alter disease onset, progression, and/or neurodegeneration ( Fig. 4 ).
Alternatively, differentially expressed genes may define non-causal perturbations-such changes may represent candidates as biomarkers for the neuronal injury accompanying neurofibrillary tangle pathology. In order to identify potential causal gene expression changes, we integrated our findings with available results from 3 published, unbiased Drosophila screens, together defining 84 genetic modifiers of Tau-mediated neurotoxicity [25] [26] [27] . Among these, 37 genes were differentially expressed in the transcriptome and/or proteome (either Tau WT or Tau R406W ) ( Table 4 and Additional File 2: Table S9 ).
Next, for each of these 37 genes, we examined the direction of modifier tests from the literature to resolve whether the Tau-induced gene expression changes (up-or down-regulation) represent "amplifying" versus "protective" responses-that is, whether the observed perturbation in expression likely mediates or rather compensates for Tau-induced neuronal injury ( Fig. 4) . Up-regulated genes were defined as "amplifying" if genetic knockdown suppressed Tau toxicity and/or if overexpression reciprocally enhanced Tau phenotypes. For example, expression of Ubiquitin activating enzyme 1 (Uba1), a regulator of axon pruning, autophagy, and apoptosis [44] [45] [46] , is significantly increased in Tau R406W flies. In Table S6 ), which are similarly characterized by ageassociated up-regulation but reveal opposing Tau-associated perturbations. Overall, we identify 18 amplifying (A) and 19 protective (P) gene expression changes induced by Tau. Thus, our transcriptome and proteome data can be integrated with genetic modifier studies to reconstruct a causal chain linking Tau, specific gene expression perturbations, and neurodegeneration. Moreover, 21 out of the 37 genes with published modifiers are also differentially expressed in one of the human datasets (Table 4 and Additional File 2: Table S8 ). For example, CHD5 (homolog of Mi-2) is decreased in human brains with AD pathology. Based on the complementary studies of fly Mi-2, we can infer a potential Tau-triggered protective perturbation. These results demonstrate how Drosophila gene expression and genetic manipulation can be integrated to annotate human data for potential causal changes.
Discussion
We present an integrated, longitudinal analysis of the aging brain in Drosophila tauopathy models. Our results identify perturbations affecting thousands of transcripts and hundreds of proteins triggered by expression of human Tau and highlight many promising biological pathways that likely contribute to neurodegeneration in tauopathy. Among these, regulators of innate immunity, the cytoskeleton, endocytosis, and synaptic transmission, have independent support from genome-wide association studies of AD [47, 48] , neurofibrillary tangle burden [49] , and PSP [50] , consistent with causal roles. Although expressed at similar levels, Tau R406W , which causes familial FTD, was associated with a stronger impact on gene expression than Tau WT , inducing up to 7-fold increased response in gene expression. This result is consistent with the enhanced neurotoxicity of Tau R406W in Drosophila [24, 51] , as well as the more aggressive clinical profile of familial FTD compared to late-onset AD [1, 2] . Nevertheless, we observed strong overlap in the differential expression signatures of wildtype and mutant Tau, suggesting shared mechanisms.
Prior studies have profiled brain gene expression in Tau transgenic animals, including in flies [31, 32, 52] and mouse models [21, 23, 41] ; however, none to our knowledge have longitudinally assessed both transcripts and proteins in parallel. Our analyses provide a glimpse of the dynamic regulatory crosstalk between the brain transcriptome and proteome that respond to brain injury, as in tauopathy.
Remarkably, 42% of Tau-induced expression changes were discordant, with transcript and protein changing in opposite directions. This result is largely consistent with other emerging findings of surprisingly poor correlation between mRNA and protein levels among a variety of experimental systems [13, 17, [53] [54] [55] , including analyses of human postmortem brain tissue [18, 19, 56] . In one notable study relevant to AD, a similar fraction (40%) of differentially expressed transcripts in the 5XFAD amyloid precursor protein transgenic mouse showed discordant changes in the proteome [57] . Many discordant changes likely reflect regulatory feedback interactions that maintain protein homeostasis. Consistent with this, we found that transcript-protein concordance varied among coexpressed, and therefore likely coregulated, gene sets. Our longitudinal data also provides clues to primary perturbations in selected cases (e.g. Sar1 in Figure 2) ; however, additional studies will be needed to confirm. Ultimately, successful translation from expression profiling studies requires unambiguous determination of whether a gene of interest is up-or down-regulated, but interpretation is currently limited by transcriptome-only analyses in most cases. Indeed, whether for nomination of potential therapeutic targets or development of diagnostic biomarkers, it will be essential to understand consequences at the protein level. We note that, among all differentially expressed transcripts, only a minority (~4%) were significantly and concordantly differentially expressed proteins--the remainder were either non-significantly differentially expressed, significant but discordant, or not detected at all by proteomics. Nevertheless, despite the comparatively reduced coverage of proteomics (~2,800 proteins vs. ~17,000 transcripts), many differentially expressed genes would not have been detected at all based on isolated transcriptional profiling. Thus, our results reinforce the value of proteomics for future investigations.
Age is the strongest known risk factor for AD, and aging-dependent progression is a defining feature of AD and other neurodegenerative tauopathies. As in studies of human postmortem tissue, most gene expression analyses of tauopathy models have been cross-sectional, partially obscuring the impact of aging and potential interactions with Tau-mediated changes. In our analyses, the majority (~70%) of Tautriggered transcripts or proteins overlapped with those changes observed in aged control animals.
Importantly, our longitudinal experimental design permitted identification of Tau-associated expression changes robust to aging adjustment. Remarkably however, even after adjustment, most Tau-mediated perturbations overlap with those seen in aging, and our cross-species analysis suggests consistent results for human tauopathy expression signatures. In short, our findings suggest that Tau pathology primarily modulates the endogenous gene expression programs of brain aging. Indeed, following hierarchical clustering, 4 out of 6 differentially expressed gene sets mirrored aging expression patterns, consistent with either Tau-accelerated or delayed aging. These complementary patterns may represent disease amplifying or protective responses, respectively, as shown for Uba1 and Mi-2. Interestingly, aging was associated with a quantitatively enhanced transcriptional signature in the Tau transgenic animals, characterized by an 18% increase in differentially-expressed genes. Reciprocally, Tau expression was accompanied by a 78% reduction in age-associated changes in the proteome. Though further investigation is warranted to confirm these observations, our analyses define Tau expression signatures in the both transcriptome and proteome enriched for genes implicated in translation, including numerous ribosomal proteins. Consistent with this, pathologic forms of Tau have been shown to avidly bind ribosomal proteins and disrupt their function [40] [41] [42] .
While aging has myriad systemic and cellular targets, one key emerging theme is the dysregulation of innate immune mechanisms leading to a systemic pro-inflammatory state, which has been termed "immunosenescence" or "inflamm-ageing" [58, 59] . In our analysis, innate immune pathways were strongly enriched among both aging-and Tau-associated, differentially expressed genes, and this result is consistent with brain gene expression profiling in mouse models of healthy aging [23, 60] and tauopathy [61, 62] . Similarly, multiple transcriptome-and proteome-wide analyses of human postmortem brain from AD or other tauopathies, such as PSP, have identified evidence of dysregulated immune pathways [9] [10] [11] 18] , and similar signatures have been implicated in brains from aged individuals without known neurodegenerative disease [63, 64] . Importantly, genome-wide association studies in AD highlight an abundance of susceptibility gene candidates implicated in immune regulation (e.g. TREM2, CD33, CR1), strongly suggesting a causal role in disease pathogenesis [48] . Further, polygenic modeling [65] and analyses of human cortical transcriptomes [66] converge to implicate activated microglia in the development of Tau pathology and susceptibility for AD. Numerous follow-up studies, including in mouse and cellular models, implicate microglia and astroglia with potential roles in propagating a pathogenic inflammatory cascade [67] . However, the prevailing mechanistic models of neuroinflammation in AD have largely focused on amyloid-beta as an upstream trigger and tau pathology as a downstream consequence, and the role of aging per se is often minimized. Nevertheless, primary tauopathies lacking amyloid pathology, such as PSP, and corresponding mouse models manifest prominent neuroinflammatory brain expression signatures. By contrast with mammals, neurons significantly outnumber glia in the Drosophila brain, and true microglial cells are not present in invertebrates [68] . Nevertheless, innate immune pathways are evolutionarily ancient, and toll-like receptor signaling components are not only expressed in fly neurons and glia, but they are required for brain maintenance in aging [39, 69] . In the future, single-cell RNA-seq in Drosophila models of tauopathy may permit dissection of which cell types generate immune expression signatures along with complementary cell-type specific manipulations to confirm potential causal roles.
Gene expression profiling has emerged as a promising tool for functional genomic dissection of AD and other tauopathies; however, interpretation of these data can be powerfully enhanced by integration with complementary studies in model organisms. We have performed several cross-species analyses to highlight applications of our Drosophila tauopathy resource. One important challenge is to differentiate those gene expression changes specifically provoked by Tau-mediated mechanisms. Besides the influence of aging and life experiences, human brains commonly accumulate mixed pathologies [16] .
By contrast, experimental models permit precisely-controlled manipulations that can isolate the responsible causal triggers. Roughly half of all conserved, differentially-expressed genes from the largest available analyses of human AD or PSP brain tissue were annotated as Tau-induced perturbations based on our Drosophila experiment. Remarkably, an even larger proportion of expression changes (70%) were triggered by aging and we observed virtually complete overlap between Tau-and aging-associated changes. This result reinforces the intimate connection between the impact of neurodegenerative pathologies and aging on brain gene expression. Another major challenge following human gene expression analyses is to differentiate proximal causal pathways from more downstream, non-causal consequences of neurodegeneration. Experimental models permit controlled manipulations that mimic observed expression changes along with assessments to define potential impact on neurodegenerative phenotypes. In particular, Drosophila offers high-throughput genetics enabling unbiased, large-scale genetic screens for modifiers of Tau-mediated neurotoxicity [25] [26] [27] . By integrating these results with our RNA-seq findings, and cross-referencing with human gene expression profiles, we successfully highlight genes altered in human tauopathy that are strong candidates for further investigation as either amplifying or protective causal modifiers. In the future, targeted genetic manipulations of other conserved, differentially-expressed transcripts and/or proteins will significantly extend the value of our cross-species resource. 25°C with ambient light conditions, and aged to 1-, 10-, or 20-days following eclosion. We confirmed expression of Tau at similar levels in elav > Tau WT and elav > Tau R406W flies using western blot analysis, as previously described [40] using the following antibodies: rabbit anti-Tau (1:5000, Dako); rabbit anti-GAPDH (1:5000, GeneTex) and HRP-conjugated anti-rabbit (1:10000, Santa Cruz).
Methods
Drosophila stocks and husbandry
UAS-Tau
Drosophila RNA-sequencing data
The Drosophila RNA-sequencing (RNA-seq) dataset analyzed for this work was generated as part of another study, where it is described in detail [40] . Briefly, for elav>Tau and elav controls, animals were evaluated at 1-, 10-, or 20-days. To avoid possible batch effects, experimental and control genotypes used for each comparison (Tau WT and Tau R406W ) were sequenced together, such that 2 separate control datasets were generated (control 1 and control 2, respectively) for the Tau WT and Tau R406W RNA-seq analyses.
Triplicate samples (n=3) were used for all genotypes and time points, except for the elav control genotype used for the comparison with Tau R406W (control 2), for which duplicate samples were used (n=2):
Exp
Replicates (n) Ctrl Replicates (n) Age (d)
Tau WT 3 elav 3 1, 10, 20
Tau R406W 3 elav 2 1,10, 20
Total RNA was extracted from approximately 100 adult fly heads (for each genotype/age/sample), equally divided between males and females. Sequencing was performed on the Illumina HiSeq with 100bp paired-end reads. Gene expression values from each sample were quantified as the number of reads mapped (to a specific gene) by setting --quantMode to GeneCounts in STAR 2.5.3a [70] . Unsupervised clustering of samples was assessed by UMAP using DESeq2 depth normalized read counts as described in [71] . Figure S3 ). Missing proteomic LFQ values were imputed on a per sample basis as previously described in [72] . Missing values were imputed by drawing from a Gaussian distribution simulating expression near the LFQ detection limit, a down-shift of 1.8 standard deviations from the median sample expression. For quality assurance, we tabulated for each protein the number of replicate samples with complete data (non-imputed), broken down by genotype and age (Additional File 2: Table S10 ). For subsequent differential expression analyses, LFQs for the minority of proteins with multiple detected isoforms (n=83) were collapsed to a single value by taking the per sample mean. Abundance data for UniProt peptide IDs that did not map to a fly gene symbol were excluded from analysis.
Protein extraction and mass-spectrometry
Analysis of differentially expressed transcripts and proteins
Differential-expression analysis of transcripts and proteins was performed using DESeq2 [73] . As detailed above, for transcriptome analyses, elav>Tau WT or elav>Tau R406W were compared with the batch- SeT AnaLysis Toolkit [74] . All ORA analyses were conducted using the R implementation of WEBGESTALT. The minimum number of genes per category was set to 5. We employed the following databases: GO biological processes, GO molecular functions, GO cellular component, KEGG, and
Panther. Enrichment significance was defined using Fisher's exact test, followed by the Benjamini-Hochberg procedure; significance was set at FDR < 0.05.
Hierarchical Clustering and WGCNA analysis
Hierarchical clustering was performed to evaluate Tau R406W -associated, differentially-expressed transcripts (n = 4,992 genes), based on the joint regression model (Fig. 1b) . Normalized expression counts for differentially-expressed genes were used as input. Pearson correlation was used as the distance metric and the complete linkage was used for distance calculation. Heatmaps of hierarchically clustered transcripts were generated using the heatmap.2 function from the gplots package in R. Based on a nonnegative matrix factorization (NMF) rank survey using the NMF package in R [75] , the optimal number of clusters was determined to be 6, maximizing cophenetic scores while minimizing residuals (Additional File 1: Figure S9 ). This was applied to the clustering as a manual tree cut to yield 6 final clusters.
Functional enrichment for cluster gene set was performed as described above. Concordance between transcripts in each cluster with corresponding proteins detected in the Tau R406W proteomic data was further evaluated by comparing the directions of log2 fold-changes. Median expression counts of genes belonging to each cluster were calculated from normalized expression values from all replicates in each genotype (Tau R406W or control set 2) and age.
Weighted gene coexpression network analysis (WGCNA) [76] was performed on expression counts from all Tau R406W transcripts (n = 10,217 genes) after normalization in DESeq2 (median-of-ratios depth normalization). The soft threshold parameter was set at 5, deepSplit = 4, and minimum module size = 23.
Expression behavior of WGCNA modules were summarized by calculating module "eigengenes". 
Drosophila and human gene set overlaps
In order to evaluate human-fly gene set overlaps, we first determined the fly homologs for all human AD, tangle, or PSP differentially-expressed genes using the DRSC Integrated Ortholog Prediction Tool (DIOPT; [43] ), applying a minimum DIOPT score threshold of 5 (Additional File 2: Table S8 ). Where more than one fly homolog had a DIOPT score > 5, all were included. We then computed enrichments of each human-derived data set (fly homologs) for either (i) Tau-or (ii) age-induced differentially expressed gene sets, based on our experimental analyses in Drosophila models, using the phyper base function of R 
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Not applicable. Tables S2 and S3 for complete results. Table 3 : Tau-and aging-induced changes from cross-species overlaps. We examined differentially expressed transcripts from published RNA-seq analyses of human postmortem brain, including AD cases/controls [10] , PSP cases/controls [9] , or quantitative neurofibrillary tangle burden [11] . We also considered complementary mass-spectrometry proteomics from AD brains [19] . The total number of unique, differentially expressed human genes are noted along with the subset that are conserved in Drosophila. Among conserved genes, we examined the number and percentage with Tau-or agingtriggered differentially expressed homologs in flies. Given the reduced coverage of proteomics, we only consider conserved human proteins in which the homologous fly proteins were also detected in our assay.
TABLES
See Additional File 2: Tables S8 for complete results.   Table 4 Drosophila Human
Gene
Amplifying vs. Protective AD Tangles are modifiers of Tau-mediated neurodegeneration based on published unbiased screens [25] [26] [27] .
Direction of Tau-induced differential expression is noted, including up-(top) or down-regulation (bottom) of transcripts. Based on the results of modifier tests, we can infer whether the observed Tau-induced expression perturbation is amplifying (A) or protective (P) for Tau neurotoxicity. See also Figure 4 and Additional File 2: Table S8 and S9. For each fly gene, we also note whether human gene homolog(s) are differentially expressed in human postmortem brain tissue from published analyses of AD [10] and neurofibrillary tangle burden [11] . In cases where the direction of expression was concordant with Drosophila, the human gene name is indicated in boldface. In a smaller PSP dataset [9] , only 1 fly gene, mub, had a differentially-expressed human homolog, PCBP4. See Fig. 2 and Additional File 1: Figure S5 for selected examples (labeled). 
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